Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Advanced Research Technologies Inc.

BioPhotonics
May 2006
Advanced Research Technologies Inc. of Saint-Laurent, Quebec, Canada, has announced clinical trials for the SoftScan optical breast imaging system. The device uses time-domain optical imaging to characterize tumors as benign or malignant. Differences in optical signatures between tissues indicate vascularization, cellularity, oxygen consumption, edema, fibrosis and remodeling.

The study will continue through 2006 at several North American centers and examine 600 to 950 volunteer patients age 25 to over 60. The company intends to present results in its submission to Health Canada and the FDA to support its premarket approval application.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!